These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2859693)

  • 1. Widespread occurrence of AP in amyloidotic tissues. An immunohistochemical observation.
    Shirahama T; Skinner M; Sipe JD; Cohen AS
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(3):197-206. PubMed ID: 2859693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical identification of amyloid in formalin-fixed paraffin sections.
    Shirahama T; Skinner M; Cohen AS
    Histochemistry; 1981; 72(2):161-71. PubMed ID: 7024214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of amyloid in murine and human secondary amyloidosis by the immunoperoxidase technique.
    Livni N; Laufer A; Levo Y
    J Pathol; 1980 Dec; 132(4):343-8. PubMed ID: 7003080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical identification of generalized AA-amyloidosis in a mountain gazelle (Gazella gazella).
    Linke RP; Hol PR; Geisel O
    Vet Pathol; 1986 Jan; 23(1):63-7. PubMed ID: 3511600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
    Hind CR; Tennent GA; Evans DJ; Pepys MB
    J Pathol; 1983 Feb; 139(2):159-66. PubMed ID: 6338184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of amyloid P component, apolipoprotein E and ubiquitin in human and murine amyloidoses.
    Cui D; Hoshii Y; Takahashi M; Kawano H; Iwata T; Ishihara T
    Pathol Int; 1998 May; 48(5):362-7. PubMed ID: 9704343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor.
    Varga J; Flinn MS; Shirahama T; Rodgers OG; Cohen AS
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(3):177-85. PubMed ID: 2874651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous amyloidosis of the mouse. 3. Two patterns of amyloid distribution and their pathogenic relationship.
    Zschiesche W
    Acta Pathol Microbiol Scand Suppl; 1972; 233():135-40. PubMed ID: 5074623
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical characterization of amyloid fibril precursors in renal tissue.
    Wagrowska-Danilewicz M; Danilewicz M
    Acta Histochem; 1996 Jul; 98(3):301-8. PubMed ID: 8863859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of amyloid P component in cerebro-vascular amyloidosis.
    Rowe IF; Jensson O; Lewis PD; Candy J; Tennent GA; Pepys MB
    Neuropathol Appl Neurobiol; 1984; 10(1):53-61. PubMed ID: 6377111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid. VI. A comparison of two morphologic components of human amyloid deposits.
    Glenner GG; Keiser HR; Bladen HA; Cuatrecasas P; Eanes ED; Ram JS; Kanfer JN; DeLellis RA
    J Histochem Cytochem; 1968 Oct; 16(10):633-44. PubMed ID: 5688086
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis.
    Breathnach SM; Bhogal B; Dyck RF; De Beer FC; Black MM; Pepys MB
    Br J Dermatol; 1981 Aug; 105(2):115-24. PubMed ID: 7025878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic amyloidosis: morphologic differences between systemic AL and AA types.
    Buck FS; Koss MN
    Hum Pathol; 1991 Sep; 22(9):904-7. PubMed ID: 1916751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high resolution ultrastructural study of experimental murine AA amyloid.
    Inoue S; Kisilevsky R
    Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
    Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
    Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.